We are live on ! Find out more
PTJ

Paul Tudor Jones Tudor Investment Corp

AUM $71.9B
1-Year Est. Return 42.37%
 

Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.

This Fund
S&P 500
This Quarter Est. Return
+12.78%
1 Year Est. Return
+42.37%
3 Year Est. Return
+108.76%
5 Year Est. Return
+114.43%
10 Year Est. Return
+640.77%
AUM
$12.4B
AUM Growth
+$2.44B
Cap. Flow
+$1.26B
Cap. Flow %
10.16%
Top 10 Hldgs %
13.44%
Holding
3,052
New
826
Increased
775
Reduced
631
Closed
756

Sector Composition

Rank Sector Weight
1 Technology 12.01%
2 Industrials 7.52%
3 Financials 6.7%
4 Healthcare 6.53%
5 Consumer Discretionary 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGM icon
2676
MGM Resorts International
MGM
$11B
-353,017
Closed -$13M
MGM icon
2677
PUT
MGM Resorts International
MGM
$11B
-36,000
Closed -$1.32M
MGNX icon
2678
MacroGenics
MGNX
$261M
-139,080
Closed -$648K
MGPI icon
2679
MGP Ingredients
MGPI
$387M
-28,296
Closed -$2.98M
MHO icon
2680
M/I Homes
MHO
$3.85B
-53,861
Closed -$5.39M
MIRM icon
2681
Mirum Pharmaceuticals
MIRM
$5.87B
-19,104
Closed -$604K
MKTX icon
2682
CALL
MarketAxess Holdings
MKTX
$5.71B
-2,700
Closed -$577K
MKTX icon
2683
MarketAxess Holdings
MKTX
$5.71B
-46,925
Closed -$10M
MKTX icon
2684
PUT
MarketAxess Holdings
MKTX
$5.71B
-1,700
Closed -$363K
MLAB icon
2685
Mesa Laboratories
MLAB
$698M
-3,170
Closed -$333K
MLI icon
2686
Mueller Industries
MLI
$14B
-12,828
Closed -$241K
MLM icon
2687
CALL
Martin Marietta Materials
MLM
$32.1B
-6,600
Closed -$2.71M
MLM icon
2688
Martin Marietta Materials
MLM
$32.1B
-7,436
Closed -$3.05M
MLM icon
2689
PUT
Martin Marietta Materials
MLM
$32.1B
-1,900
Closed -$780K
MRSH
2690
CALL
Marsh
MRSH
$91.6B
-3,900
Closed -$742K
MMI icon
2691
Marcus & Millichap
MMI
$1.22B
-11,773
Closed -$345K
MMM icon
2692
3M
MMM
$92.3B
-17,300
Closed -$1.39M
MNSO icon
2693
MINISO
MNSO
$3.29B
-21,757
Closed -$564K
MOD icon
2694
CALL
Modine Manufacturing
MOD
$10.5B
-12,700
Closed -$581K
MOD icon
2695
PUT
Modine Manufacturing
MOD
$10.5B
-24,100
Closed -$1.1M
MOG.A icon
2696
Moog Inc Class A
MOG.A
$12.3B
-30,261
Closed -$3.42M
MOV icon
2697
Movado Group
MOV
$774M
-7,767
Closed -$212K
MPWR icon
2698
CALL
Monolithic Power Systems
MPWR
$64.7B
-500
Closed -$231K
MPWR icon
2699
PUT
Monolithic Power Systems
MPWR
$64.7B
-1,100
Closed -$508K
MRK icon
2700
Merck
MRK
$376B
-84,792
Closed -$8.8M

Similar funds

Paul Tudor Jones's Q4 2023 Portfolio in Review

As of Q4 2023, Paul Tudor Jones held 3,052 positions worth $12.4B, up 25% from $9.97B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Paul Tudor Jones deployed $1.26B of net new capital in Q4 2023, opening 826 new positions and adding to 775 existing holdings. Its largest new stake was ExxonMobil: 640,101 shares worth $64M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $64.6M trimmed.

  • Paul Tudor Jones's largest Q4 2023 buy was ExxonMobil: 640,101 shares worth $64M.
  • Paul Tudor Jones added most to Pioneer Natural Resource Co. in Q4 2023, an estimated $185M increase.
  • Paul Tudor Jones's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $64.6M.
  • Paul Tudor Jones fully exited Activision Blizzard in Q4 2023, selling an estimated $284M.
  • Paul Tudor Jones's ten largest holdings make up 13% of its $12.4B portfolio in Q4 2023.
  • Paul Tudor Jones opened 826 new positions and closed 756 in Q4 2023.
  • Paul Tudor Jones's portfolio value rose 25% quarter-over-quarter to $12.4B.

Based on Tudor Investment Corp's 13F filing for Q4 2023, filed 14 Feb 2024.